We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
- Authors
Nemeroff, Charles B; Kalali, Amir; Keller, Martin B; Charney, Dennis S; Lenderts, Susan E; Cascade, Elisa F; Stephenson, Hugo; Schatzberg, Alan F
- Abstract
IMS Health Inc data presented by the Food and Drug Administration (FDA) on September 13 and 14, 2004, at a joint meeting of the Center for Drug Evaluation and Research's Psychopharmacologic Drugs Advisory Committee and the FDA's Pediatric Advisory Committee suggested that the number of children and teenagers who were prescribed antidepressants continued to increase in 2004, despite widespread publicity surrounding 2 FDA advisories regarding the potential for pediatric suicidality with selective serotonin reuptake inhibitor use. These results are contradictory to findings from the Medco Health Solutions, Inc, March 2004 analysis of pharmacy benefit claims and a separate subsequent analysis conducted by NDC Health using dispensing data from March 31, 2004, through June 30, 2005.
- Publication
Archives of general psychiatry, 2007, Vol 64, Issue 4, p466
- ISSN
0003-990X
- Publication type
Journal Article
- DOI
10.1001/archpsyc.64.4.466